CLEC12B suppresses lung cancer progression by inducing SHP-1 expression and inactivating the PI3K/AKT signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CLEC12B suppresses lung cancer progression by inducing SHP-1 expression and inactivating the PI3K/AKT signaling pathway

Published:2021-12 Issue:2 Volume:409 Page:112914
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Chi Decai,Wang Dong,Zhang Minghui,Ma Hui,Chen Fuhui,Sun Yajiao^ORCID

Funder

Harbin Medical University Cancer Hospital

China Postdoctoral Science Foundation

Natural Science Foundation of Heilongjiang Province

Heilongjiang Provincial Postdoctoral Science Foundation

National Mega Project on Major Infectious Disease Prevention

Publisher

Elsevier BV

Subject

Cell Biology

Reference47 articles.

1. Cancer statistics;Siegel;Ca - Cancer J. Clin.,2019

2. Lung cancer;Brody;Nature,2020

3. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin. Proc.,2008

4. The biology and management of non-small cell lung cancer;Herbst;Nature,2018

5. Small in size, but large in action: microRNAs as potential modulators of PTEN in breast and lung cancers;Abadi;Biomolecules,2021

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism study of tyrosine phosphatase shp-1 in inhibiting hepatocellular carcinoma progression by regulating the SHP2/GM-CSF pathway in TAMs;Scientific Reports;2024-04-21

2. SHP-1 interacts with NFκB1 to inhibit its phosphorylation and nuclear translocation to suppress excessive bacterial inflammation;2024-04-14

3. Myeloid C-type lectin receptors in innate immune recognition;Immunity;2024-04

4. Mechanisms of polydatin against spinal cord ischemia–reperfusion injury based on network pharmacology, molecular docking and molecular dynamics simulation;Bioorganic Chemistry;2023-11

5. PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation;European Journal of Pharmacology;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3